Adamed to participate in BIO-Europe Spring 2012

About Adamed
About Adamed
Adamed in Poland
Adamed across the globe
Management Team of Adamed Pharma S.A.
Mission and values
Ethics and Compliance
Adamed for the Family
News
Adamed is a pharmaceutical and biotechnology company with almost 40 years of experience, founded on the basis of Polish scientific advances and a patent portfolio.
Products
Produkty
Prescription drugs
OTC drugs
Dietary supplements
Dermocosmetics
Medical devices
We provide patients with the highest quality medicinal products that are a response to chronic civilization diseases in several therapeutic areas.
Development and innovation
Development and innovation
Research
Development of proprietary medicines
Development of value-added medicines
Business development Startups Requests for proposals and tenders
Innovation is at the core of Adamed’s evolution. It allows us to pursue our mission by responding to the key challenges of modern medicine.
ESG
CSR
Adamed Foundation
Social programmes
Code of Ethics
Responsibility is one of our key values. It is at the core of everything we do and has earned us the trust of patients and the medical community.
Career
Career
Benefits
Development
Locations
Internships and apprenticeships
People are a priority at Adamed, and their passion and dedication has helped us grow into a successful company. Recognising the value of our staff, we are committed to providing excellent work conditions and career opportunities.
Contact

Global English

Popular searches Innovations About Adamed Business Development Adamed worldwide Researches

x

Events

24 February 2012

Each year BIO-Europe Spring attracts pharma and biotech companies, financial investors, R&D service providers and innovative start-ups. Last year, the conference has been visited by delegates from 47 countries that participated in thousands of bilateral meetings. Beside partnering, BIO-Europe Spring offers access to thought-leading presentations, panel discussions and workshops.
BIO-Europe Spring 2012 is an excellent opportunity to meet our research team and get familiar with our drug discovery programs for cancer, metabolic disorders and central nervous system diseases.

Should you be willing to meet, please contact:
Lukasz Kalinowski
Head of Drug Discovery
lukasz.kalinowski@adamed.com.pl

For more information on BIO-Europe please visit:
www.ebdgroup.com/bes